InvestSMART

Imricor Medical Systems Inc (ASX: IMR) - Announcements

Current share price for IMR : $1.570 0.02 (1.29%)+

ASX company news and announcements for Imricor Medical Systems Inc (IMR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Imricor Medical Systems Inc (IMR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Imricor Medical Systems Inc (IMR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Imricor Medical Systems Inc (IMR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$563 Cleansing Notice 14 Sep 2021 9:41AM $1.190 $1.570 risen by 31.93%
$563 Response to ASX Query 14 Sep 2021 9:34AM $1.190 $1.570 risen by 31.93%
$563 Change in substantial holding 13 Sep 2021 5:44PM $1.190 $1.570 risen by 31.93%
$563 Application for quotation of securities - IMR 13 Sep 2021 9:52AM $1.220 $1.570 risen by 28.69%
$563 Investor Presentation 9 Sep 2021 3:06PM $1.250 $1.570 risen by 25.60%
$563 Proposed issue of securities - IMR 8 Sep 2021 10:42AM $1.035 $1.570 risen by 51.69%
$563 Proposed issue of securities - IMR 8 Sep 2021 10:41AM $1.035 $1.570 risen by 51.69%
$563 Successful Completion of Placement and Launch of SPP 8 Sep 2021 10:40AM $1.035 $1.570 risen by 51.69%
$563 Trading Halt 7 Sep 2021 8:50AM $1.035 $1.570 risen by 51.69%
$563 Application for quotation of securities - IMR 1 Sep 2021 1:18PM $1.120 $1.570 risen by 40.18%
$563 Imricor Signs Sales Agreement with NordicNeuroLab 30 Aug 2021 9:43AM $1.225 $1.570 risen by 28.16%
$563 HY21 Investor Presentation 26 Aug 2021 8:00AM $1.230 $1.570 risen by 27.64%
$563 Imricor releases Half Year Results for 1H 2021 26 Aug 2021 8:00AM $1.230 $1.570 risen by 27.64%
$563 Appendix 4D and Half Year Report & Accounts 26 Aug 2021 8:00AM $1.230 $1.570 risen by 27.64%
$563 Upcoming Release from Escrow Notification 20 Aug 2021 9:15AM $1.205 $1.570 risen by 30.29%
$563 Application for quotation of securities - IMR 12 Aug 2021 10:54AM $1.390 $1.570 risen by 12.95%
$563 Details of Imricor HY21 Results Investor Briefing 10 Aug 2021 9:09AM $1.500 $1.570 risen by 4.67%
$563 Notification of cessation of securities - IMR 4 Aug 2021 9:27AM $1.550 $1.570 risen by 1.29%
$563 TGA Approval Received for Advantage-MR System 4 Aug 2021 9:21AM $1.550 $1.570 risen by 1.29%
$563 Appendix 4C - Quarterly Report and Business Update 29 Jul 2021 8:52AM $1.850 $1.570 fallen by 15.14%
$563 Application for quotation of securities - IMR 16 Jun 2021 10:22AM $1.550 $1.570 risen by 1.29%
$563 Notification regarding unquoted securities - IMR 10 Jun 2021 11:00AM $1.500 $1.570 risen by 4.67%
$563 Appendix 3Y - AM 13 May 2021 9:10AM $1.980 $1.570 fallen by 20.71%
$563 Appendix 3Y - PM 13 May 2021 9:09AM $1.980 $1.570 fallen by 20.71%
$563 Appendix 3Y - MT 13 May 2021 9:09AM $1.980 $1.570 fallen by 20.71%

426 - 450 of 602 results

Page 18 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.